https://interactions.guidetherapeutiquevih.com/en/interaction-details?id=18399
No pharmaceutical opinion available for this interaction.
Cobicistat may inhibit the metabolism (CYP2D6) and decrease the conversion into morphine, active metabolite of Codeine.
–
–
–
Possible decrease of clinical efficacy.
Monitor for clinical efficacy and adjust the dosage if necessary.
Hydromorphone or morphine.
Signs and symptoms of opioid withdrawal : craving for opioids, irritability, myalgias, muscle spasms, flushing, abdominal pain, nausea, vomiting, diarrhea, restlessness, diaphoresis, lacrimation, rhinorrhea, mydriasis, yawning, piloerection (goose flesh), tachycardia, tremulousness.
–
–
–
–